📰 First Approved News
First Approved News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from First Approved. Real-time updates on events, politics, business and more.
January 24, 2024
As the treatment paradigm in urothelial cancer expands to include agents directed at various targets, NECTIN-4 has emerged as a promising treatment target.
January 8, 2024
Targeting first approved product in 2026 towards realizing mission of bringing new, potential best-in-class treatments to patients with cancer
October 24, 2023
Celltrion announced that the FDA has approved its subcutaneous formulation of Zymfentra® (infliximab -dyyb), biosimilar to Janssen’s Remicade®, as…
May 4, 2023
FTSE 100 Poised to Fall After Mixed Asia, US Losses 0630 GMT - The FTSE 100 looks set to open 28 points lower at 7760 after mixed trading in Asia and a lower close on Wall Street. Markets in mainland China and South Korea fall and Australian shares... | 02:53am
April 19, 2022
/PRNewswire/ -- The "Unituxin Patent, Sales & Clinical Trials Outlook 2028" report has been added to ResearchAndMarkets.coms offering. Global Unituxin market...
February 1, 2022
Read the latest Thai Economy headlines, all in one place, on NewsNow: the one-stop shop for news
October 6, 2021
/PRNewswire/ -- "Global EZH2 Inhibitor Market Opportunity, Sales & Clinical Trials Insight 2026" Report Highlights: Global EZH2 Inhibitor Market Opportunity >...
October 6, 2021
NEW DELHI, Oct. 6, 2021 /PRNewswire/ -- "Global EZH2 Inhibitor Market Opportunity, Sales & Clinical Trials Insight 2026" Report Highlights: Global EZH2 Inhibitor Market Opportunity > US$
October 6, 2021
/PRNewswire/ -- "Global EZH2 Inhibitor Market Opportunity, Sales & Clinical Trials Insight 2026" Report Highlights: Global EZH2 Inhibitor Market Opportunity >...
May 11, 2021
Share this article Share this article ResearchAndMarkets.coms offering. Global Bispecific Antibody Market Opportunity, Drug Sales, Price & Clinical Trials Insight 2028 report findings, it is predicted that in the next few successful years of clinical research studies associated with the therapy, it will lead to completely revolutionize the entire cancer treatment regimen and the overall future direction of cancer therapeutics. By growing at an accelerated speed in small period of time, the ther...